AUG 15, 2026 · JOURNAL ARTICLE
AA amyloidosis as a renal immune-related adverse event of immune checkpoint inhibitors: mechanisms, diagnosis, and management
Expert Review of Anticancer Therapy
A narrative review synthesizing case reports and pharmacovigilance signals to propose mechanisms linking ICI use to AA amyloidosis; the source explicitly states mechanisms are hypotheses rather than confirmed pathways and evidence remains scarce with causality unestablished.
Reported
Case reports in literature11
Pharmacovigilance reports (FAERS)26